AMWL · American Well Corp · Metrics
Market Cap
$230.30M
Shares
17.01M
Volume · Oct 26
130.86K
Avg daily vol (3M)
106.69K
AMWL metrics
83 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$13.54
Market cap
$230.30M
Price action
20 metricsPrice change (1W)
+16.2%
Price change (30D)
+1.0%
Price change (3M)
+25.5%
Price change (6M)
+130.8%
Price change (YTD)
+176.4%
Price change (1Y)
+146.3%
Trailing year
Price change (5Y)
—
52-week high
$14.19
52-week low
$3.78
Change from 52-week high
-4.4%
Change from 52-week low
+259.0%
Annualized volatility
71.8%
Annualized volatility (3M)
69.6%
Beta
1.0
RSI (14D)
56.4
Price vs SMA 50
+6.3%
Price vs SMA 200
+55.9%
Avg volume (3M)
105,937
Relative volume
1.0
Average dollar volume
$1.34M
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
17.01M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.2×
reciprocal yield 626.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.1×
reciprocal yield 94.7%
P / book
1.0
reciprocal yield 95.8%
FCF yield
-11.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-34.0%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
-0.3×
EV / revenue historical average (5Y)
0.8×
reciprocal yield 125.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-04
Profitability
9 metricsGross margin
—
Operating margin
-37.3%
Trailing 12 months
Net margin
-35.9%
Gross profit (TTM)
—
Operating profit (TTM)
−$81.46M
Net income (TTM)
−$78.46M
Trailing 12 months
Diluted EPS (TTM)
$-4.78
FCF margin
-12.1%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-26.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$218.53M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+5.5%
Year over year · more shares
Revenue CAGR (3Y)
-3.5%
Revenue CAGR (5Y)
+0.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-35.5%
Return on assets
-24.0%
Debt / equity
0.0
Current ratio
2.9
EBITDA (TTM)
−$48.91M
Free cash flow (TTM)
−$26.41M
Quick ratio
2.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$195.95M
Latest balance sheet
Cash & equivalents
$195.95M
Total assets
$327.18M
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$26.39M
Capital expenditures (TTM)
$25,000
R&D (TTM)
$55.25M
SG&A (TTM)
—
Stock compensation (TTM)
$13.00M
R&D / revenue
25.3%
Stock compensation / revenue
5.9%
Ownership (13F)
9 metrics13F filers
56
13F filer change QoQ
+1
Institutional ownership
43.4%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+20.1%
Holder tenure
13.3
Price vs estimated holder cost
-43.0%
Ownership (registered funds)
1 metricsIndex-fund ownership
4.7%
Short interest
3 metricsShort interest
1.2%
Latest settlement · 2.3 days to cover
Days to cover
2.3d
Short-squeeze score
56 / 100
Insider activity
2 metricsNet insider buying (90D)
−$431,047
Insider-sentiment score
20 / 100
Risk flags
1 metricsGoing concern
—